Cavitation Technologies, Inc. -- Independent Research Report Released with $2.04 Price Target
|
| Posted
:
Mon, 09 Nov 2009 04:55:21 GMT |
| Author
:
Cavitation Technologies, Inc. |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
LOS ANGELES, Nov. 8 /PRNewswire-FirstCall/ -- Cavitation Technologies, Inc. (CTI) (OTC Bulletin Board: CVAT; Berlin: WTC) is pleased to announce a research report has been issued on the Company by Grass Roots Research and Distribution Inc., Wall Street's leading independent research firm, with a "BUY" recommendation and a $2.04 long term price target.
To view full report please paste the following link to your browser: www.grassrootsrd.com/cvat-report.pdf
Grass Roots Research and Distribution, Inc., led by D. Paul Cohen, is one of Wall Street's ELITE Independent Research Firms. As founder of Bear Stearns Western Regional Offices, Paul Cohen was one of the original 12 Dirty Dozen analysts, regarded by many to be the top 12 security analysts in the nation. Mr. Cohen was also the West Coast Senior Vice President of CBWL-Hayden Stone-American Express. Mr. Cohen's partners were Sanford I. Weill (past Chairman and CEO of CitiGroup and past Chairman of Solomon Smith Barney) and Arthur Levitt (past Chairman of the Securities and Exchange Commission (SEC)). Grass Roots Research and Distribution, Inc. includes PhD's, MD's, and 21 analysts covering most industries. The backbone of the fundamental research targeted at stock investment includes investigative research into significant corporate events, thorough review of SEC filings, in depth financial analysis, valuations, and management profiles.
About Cavitation Technologies
Cavitation Technologies, Inc. (CTI); (OTC Bulletin Board: CVAT); is a "Green-Tech" company, established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, food and beverage, and chemical industries. For additional information please visit: www.cavitationtechnologies.com
Safe Harbor: Pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934, any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals and assumptions of future events or performance are not statements of historical fact and may be "forward-looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this release may be identified through the use of words such as "expects," "will," "anticipates," "estimates," "believes," or statements indicating certain actions such as "may," "could," or "might" occur. Such statements reflect the current views of Cavitation Technologies, Inc with respect to future events and are subject to certain assumptions, including those described in this release. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products, services, and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors. The actual results that Cavitation Technologies, Inc. achieves may differ materially from any forward-looking statements due to such risks and uncertainties. Cavitation Technologies, Inc. does not undertake any responsibility to update the "forward-looking" statements contained in this news release.
SOURCE Cavitation Technologies, Inc.
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
V is for Versatility as Hanes® Introduces V-Neck Underwear T-Shirts in Dyed Colors WINSTON-SALEM, N.C. -
The plain white underwear T-shirt, which for decades has been as
comfortable as it is stylish in its simplicity, is making room for some
color.
Hanes, the No. 1 men’s underwear brand in America, has introduced
new dyed V-neck underwea
Cossette Recommends that Shareholders Reject the Amended Cosmos Offer of $7.87 per Share
KOS (TSX)
QUEBEC CITY, Nov. 25 - Cossette Inc. ("Cossette") announced today that its Board of Directors unanimously determined (with the interested directors, being Claude Lessard and Pierre Delagr...
Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement
- Agreement Provides Financial Flexibility, Allowing Company to Access Capital at its Discretion -
LAVAL, Quebec, Nov. 25 - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced it has entered into a standby equity distribution agreement (S...
Isle of Capri Casinos Will Report FY 2010 Second Quarter Results
ST. LOUIS, Nov. 25 -- Isle of Capri Casinos, Inc. (Nasdaq: ISLE) announced today that it will release its financial results for its fiscal 2010 second quarter before the market opens on Tuesday, December 1, 2009, and will host a conference call and simultaneous w...
Dangerous Cribs Have Parents Questioning Sleeping Environments SAN ANTONIO -
The recent recall of over two million cribs has parents and safety
experts questioning the safety of infants’ and babies’ sleeping
environments. Loose blankets, crib bumper pads, soft pillows or toys and
extra fabric on clothing can all put young children at risk fo
Timken Slated to Present at Bank of America Merrill Lynch Global Industries Investor Conference CANTON, Ohio -
The Timken Company (NYSE: TKR) is scheduled to be among presenters at
the Bank of America Merrill Lynch Global Industries Investor Conference
on Dec. 9, 2009, at 1:25 p.m. Eastern Time in New York City. Presenting
will be James W. Griffith,&n
Curis to Present at Piper Jaffray 21st Annual Healthcare Conference CAMBRIDGE, Mass. -
Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to
develop next generation targeted small molecule drug candidates for
cancer treatment, today announced that the Company will be presenting at
the Piper Jaffray 21st Annual Healthcare Conference at 11:00 a.m.
|
|
|
|
|
|
|
|
|